Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 1129Triple Negative Breast Neoplasms 85Neoplasm Metastasis 62Neoplasms 40Breast Neoplasms, Male 20Prostatic Neoplasms 19Carcinoma, Intraductal, Noninfiltrating 19Neutropenia 18HER2-positive Breast Cancer 17Breast Carcinoma In Situ 17Pain 16Carcinoma, Ductal, Breast 16Hot Flashes 15Lung Neoplasms 14Inflammatory Breast Neoplasms 14Breast Diseases 14Brain Neoplasms 14Osteoporosis 13Multiple Myeloma 13Advanced Breast Cancer 13Recurrence 12Ovarian Neoplasms 12Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Ovarian Epithelial 11Testicular Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Mantle-Cell 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10

Interventions

Zoledronic Acid 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Fractures, Bone × Breast × Clear all
NCT00321464 2022-11-08

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Amgen

Phase 3 Completed
2,049 enrolled 16 charts
Breast

Breast Neoplasms, Fractures, Bone

NCT00639210 2019-02-26

BREX

Finnish Breast Cancer Group

Phase 3 Completed
573 enrolled
Breast

Breast Neoplasms, Motor Activity, Osteoporosis, Fractures, Bone, Osteoporotic Fractures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡